Illumina guidance cut largely as expected, says Barclays
Barclays views Illumina’s (ILMN) guidance last night as largely as expected. The bulls are going to defend the stock on China being de-risked, ...
Barclays Remains a Sell on Illumina (ILMN)
In a report released today, Luke Sergott from Barclays maintained a Sell rating on Illumina (ILMN – Research Report), with a price target of ...
4ILMN : Illumina Unusual Options Activity
Today, Benzinga's options scanner identified 8 options transactions for Illumina. This is an unusual occurrence. The ...
San Diego Union-Tribune10d
Illumina cuts workforce at San Diego headquarters
Gene-sequencing giant Illumina is laying off 96 employees from its San Diego headquarters, according to paperwork filed with the state. This workforce reduction comes at a time when Illumina is ...
Nasdaq2d
Illumina Unusual Options Activity
An analyst from Barclays downgraded its action to Underweight with a price target of $100. * An analyst from Canaccord Genuity persists with their Hold rating on Illumina, maintaining a target ...